Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model
Lotte K Kristensen, Camilla Christensen, Mette M Jensen, Brian J Agnew, Christina Schjöth-Frydendahl, Andreas Kjaer, Carsten H Nielsen
Dyk ned i forskningsemnerne om 'Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model'. Sammen danner de et unikt fingeraftryk.